MAPT and Alzheimer disease: Accumulating evidence shows that lincRNAs exhibit expression abnormalities during AD progression and are involved in the major mechanisms that underlie AD pathology, including regulation of Tau, production and accumulation of Aβ peptide, inflammation, and cell death.